The American
Cancer society reports that there were approximately 28,440 new cases of cancer in TN in 2007 alone.
The American
Cancer Society reports that nearl 1.5 million people will be diagnosed with cancer this year and 562,000 will die of the disease.
The American
Cancer Society reports that there were approximately 31,000 new cases of cancer in 2007 alone.
The American
Cancer Society reports that rates of skin cancer have been climbing every year for the past three decades and is one of the most common forms of cancer affecting young adults, specifically young women.
The American
Cancer Society reports that studies of people exposed to formaldehyde in the workplace have also found a possible link to cancer of the nasal sinuses.
The American
Cancer Society reports that prostate cancer is the second leading cause of cancer death in American men, behind lung cancer, with about 220,800 new cases estimated in 2015.
Given the poor prognosis and limited treatment options in pancreatic cancer, new therapies to combat the disease are desperately needed: Earlier this year, the American
Cancer Society reported that it is estimated that in 2016, nearly 42,000 people will die from the disease, surpassing the number of deaths from breast cancer by more than 1,000.
Not exact matches
Some good news in the war on breast
cancer: «From 1989 to 2015, breast cancer death rates decreased by 39 %, which translates to 322,600 averted breast cancer deaths in the United States,» according to a new report published by the American Cancer So
cancer: «From 1989 to 2015, breast
cancer death rates decreased by 39 %, which translates to 322,600 averted breast cancer deaths in the United States,» according to a new report published by the American Cancer So
cancer death rates decreased by 39 %, which translates to 322,600 averted breast
cancer deaths in the United States,» according to a new report published by the American Cancer So
cancer deaths in the United States,» according to a new
report published by the American
Cancer So
Cancer Society.
Important factors that could cause our actual results and financial condition to differ materially from those indicated in the forward - looking statements include, among others, the following: our ability to successfully and profitably market our products and services; the acceptance of our products and services by patients and healthcare providers; our ability to meet demand for our products and services; the willingness of health insurance companies and other payers to cover Cologuard and adequately reimburse us for our performance of the Cologuard test; the amount and nature of competition from other
cancer screening and diagnostic products and services; the effects of the adoption, modification or repeal of any healthcare reform law, rule, order, interpretation or policy; the effects of changes in pricing, coverage and reimbursement for our products and services, including without limitation as a result of the Protecting Access to Medicare Act of 2014; recommendations, guidelines and quality metrics issued by various organizations such as the U.S. Preventive Services Task Force, the American Cancer Society, and the National Committee for Quality Assurance regarding cancer screening or our products and services; our ability to successfully develop new products and services; our success establishing and maintaining collaborative, licensing and supplier arrangements; our ability to maintain regulatory approvals and comply with applicable regulations; and the other risks and uncertainties described in the Risk Factors and in Management's Discussion and Analysis of Financial Condition and Results of Operations sections of our most recently filed Annual Report on Form 10 - K and our subsequently filed Quarterly Reports on Form 1
cancer screening and diagnostic products and services; the effects of the adoption, modification or repeal of any healthcare reform law, rule, order, interpretation or policy; the effects of changes in pricing, coverage and reimbursement for our products and services, including without limitation as a result of the Protecting Access to Medicare Act of 2014; recommendations, guidelines and quality metrics issued by various organizations such as the U.S. Preventive Services Task Force, the American
Cancer Society, and the National Committee for Quality Assurance regarding cancer screening or our products and services; our ability to successfully develop new products and services; our success establishing and maintaining collaborative, licensing and supplier arrangements; our ability to maintain regulatory approvals and comply with applicable regulations; and the other risks and uncertainties described in the Risk Factors and in Management's Discussion and Analysis of Financial Condition and Results of Operations sections of our most recently filed Annual Report on Form 10 - K and our subsequently filed Quarterly Reports on Form 1
Cancer Society, and the National Committee for Quality Assurance regarding
cancer screening or our products and services; our ability to successfully develop new products and services; our success establishing and maintaining collaborative, licensing and supplier arrangements; our ability to maintain regulatory approvals and comply with applicable regulations; and the other risks and uncertainties described in the Risk Factors and in Management's Discussion and Analysis of Financial Condition and Results of Operations sections of our most recently filed Annual Report on Form 10 - K and our subsequently filed Quarterly Reports on Form 1
cancer screening or our products and services; our ability to successfully develop new products and services; our success establishing and maintaining collaborative, licensing and supplier arrangements; our ability to maintain regulatory approvals and comply with applicable regulations; and the other risks and uncertainties described in the Risk Factors and in Management's Discussion and Analysis of Financial Condition and Results of Operations sections of our most recently filed Annual
Report on Form 10 - K and our subsequently filed Quarterly
Reports on Form 10 - Q.
BIG DATA AND
CANCER: STANDARDIZATION With Mary Beckerle of the University of Utah; Clifford A. Hudis of the American
Society of Clinical Oncology; Greg Simon of The White House; and Clifton Leaf of Fortune —
Report by Erika Fry — Video: The Crucial Data That Will Help You Fight
Cancer — Video of the entire session
There are nearly 9,000 stores peddling tobacco in NYC, according to a new
report by the American
Cancer Society's
Cancer Action Network, which says the city is «over saturated» with cigarette retailers.
New York got mixed grades on its annual
cancer prevention report card, which pointed to serious deficiencies in funding for smoking cessation programs and failure to enact strong policies on indoor tanning salon use, an affiliate of the American Cancer Society
cancer prevention
report card, which pointed to serious deficiencies in funding for smoking cessation programs and failure to enact strong policies on indoor tanning salon use, an affiliate of the American
Cancer Society
Cancer Society said.
The American
Cancer Society has issued its annual report card, rating states on how well they are doing to prevent cancer through encouraging cancer screenings, banning smoking from public places, and smoking prevention pro
Cancer Society has issued its annual
report card, rating states on how well they are doing to prevent
cancer through encouraging cancer screenings, banning smoking from public places, and smoking prevention pro
cancer through encouraging
cancer screenings, banning smoking from public places, and smoking prevention pro
cancer screenings, banning smoking from public places, and smoking prevention programs.
The American
Cancer Society has given New York State a mixed report card when it comes to cancer preve
Cancer Society has given New York State a mixed
report card when it comes to
cancer preve
cancer prevention.
Notes to Editors The
report, «How alcohol industry organisations mislead the public about alcohol and
cancer», by Mark Petticrew, Nason Maani Hessari, Cécile Knai and Elisabete Weiderpass, will be published online in Drug and Alcohol Review at 22:00 6 September 2017 The Institute of Alcohol Studies is an independent institute bringing together evidence, policy and practice from home and abroad to promote and informed debate on alcohol's impact on
society.
A pair of scientists
reported at the American Chemical
Society meeting here today that they've developed a machine that in just minutes can detect trace compounds in the breath and diagnose diseases such as diabetes, kidney failure, ulcers, and possibly even
cancer.
But a study of mice shows that breast
cancer cells decamp in groups, and the clumps of cells have a better chance of establishing a colony than loners do, Kevin Cheung of Johns Hopkins University
reported December 7 at the annual meeting of the American
Society for Cell Biology.
The American
Cancer Society's recent annual report on cancer indicates that more than 1.7 million cancer deaths have been averted between 1991 and 2012 largely due to better preventative steps such as smoking cessation and screening for breast and colon ca
Cancer Society's recent annual
report on
cancer indicates that more than 1.7 million cancer deaths have been averted between 1991 and 2012 largely due to better preventative steps such as smoking cessation and screening for breast and colon ca
cancer indicates that more than 1.7 million
cancer deaths have been averted between 1991 and 2012 largely due to better preventative steps such as smoking cessation and screening for breast and colon ca
cancer deaths have been averted between 1991 and 2012 largely due to better preventative steps such as smoking cessation and screening for breast and colon
cancers.
Phase I / II clinical trial results
reported at the American
Society for Clinical Oncology (ASCO) Annual Meeting 2015 show promising results for investigational drug brigatinib against ALK + non-small cell lung
cancer (NSCLC), with 58 of 78 ALK + patients responding to treatment, including 50 of 70 patients who had progressed after previous treatment with crizotinib, the first licensed ALK inhibitor.
Combining radiation therapy with chemotherapy for patients with limited metastatic non-small cell lung
cancer (NSCLC) may curb disease progression dramatically when compared to NSCLC patients who only receive chemotherapy, according to a new randomized phase II clinical trial
reported today at the 59th Annual Meeting of the American
Society for Radiation Oncology (ASTRO).
Global
Cancer Facts and Figures, 2nd Edition, a
report released in 2011 by The American
Cancer Society, notes that
cancers related to changing lifestyles as nations become wealthier, including lung, breast, and colorectal tumors, continue to rise in the developing world http://www.
cancer.org/Research/CancerFactsFigures/GlobalCancerFactsFigures/global-facts-figures-2nd-ed
At a meeting last week of the International
Society for Biological Therapy of
Cancer in San Diego, California, Oncolytics Biotech of Calgary in Alberta, Canada,
reported positive results from two trials of its drug Reolysin, which contains reovirus.
Cells called
cancer - associated fibroblasts arrange a normal meshwork of fibers into straight tracks, cell biologist Begum Erdogan of Vanderbilt University in Nashville and colleagues
reported December 13 at the annual meeting of the American
Society for Cell Biology.
The protein seems to help
cancers spread in people too: 50 % of colon
cancer patients with high amounts of L1CAM protein in their tumors had the
cancer spread within 5 years of treatment, compared to only 14 % of individuals with low amounts, the researchers
reported here 13 December at a meeting of the American
Society for Cell Biology.
The blend of bacteria in the digestive tract of metastatic melanoma patients is associated with disease progression or delay in patients treated with immunotherapy, researchers at The University of Texas MD Anderson
Cancer Center
report at the 2017 annual meeting of the American
Society of Clinical Oncology.
The preliminary findings were
reported here at the
Society of Gynecologic Oncology's Annual Meeting on Women's
Cancer.
«The growing number of
cancer survivors in the U.S. makes it increasingly important to understand the unique medical and psychosocial needs of survivors,» said Carol DeSantis, MPH, American Cancer Society epidemiologist and lead author of the re
cancer survivors in the U.S. makes it increasingly important to understand the unique medical and psychosocial needs of survivors,» said Carol DeSantis, MPH, American
Cancer Society epidemiologist and lead author of the re
Cancer Society epidemiologist and lead author of the
reports.
The quest for
cancer blood tests — known as liquid biopsies — is one of the hottest areas in oncology, notes Otis Brawley, chief medical and scientific officer at the American Cancer Society, but there's a long way to go: «The tests reported so far have really terrible specificity.&
cancer blood tests — known as liquid biopsies — is one of the hottest areas in oncology, notes Otis Brawley, chief medical and scientific officer at the American
Cancer Society, but there's a long way to go: «The tests reported so far have really terrible specificity.&
Cancer Society, but there's a long way to go: «The tests
reported so far have really terrible specificity.»
«We are hopeful that the hard work that went into the development of these much - needed guidelines will pay off in improved care for the approximately 240,000 men diagnosed with prostate
cancer every year,» said Rebecca Cowens - Alvarado, MPH, principal investigator for the National Cancer Survivorship Resource Center, director of Cancer Control Mission Strategy at the American Cancer Society and co-author of the r
cancer every year,» said Rebecca Cowens - Alvarado, MPH, principal investigator for the National
Cancer Survivorship Resource Center, director of Cancer Control Mission Strategy at the American Cancer Society and co-author of the r
Cancer Survivorship Resource Center, director of
Cancer Control Mission Strategy at the American Cancer Society and co-author of the r
Cancer Control Mission Strategy at the American
Cancer Society and co-author of the r
Cancer Society and co-author of the
report.
Researchers from Sanford Health and Chronix Biomedical today announced that results from a pilot study demonstrating the utility of a new
cancer panel to detect previously undetected viral and
cancer mutations are to be
reported in a poster presentation titled «Detection of novel HPV mutations and chromosomal number imbalance (CNI) in oropharyngeal and laryngeal
cancer using next - generation sequencing (NGS)» at the American
Society of Clinical Oncology Annual Meeting (ASCO 2014) being held from May 30 through June 3, 2014 in Chicago.
The guidelines
report is published Early Online in the
Society's journal, CA: A
Cancer Journal for Clinicians.
Significant improvement with the use of a combination drug therapy for recurrent ovarian
cancer was
reported at the annual meeting of the American
Society of Clinical Oncology (ASCO) in Chicago today.
Patients with advanced
cancers who took a drug designed to relieve constipation caused by pain killers lived longer and had fewer
reports of tumor progression than
cancer patients who did not receive the drug, according to results presented Oct. 27 at the 2015 meeting of the American
Society of Anesthesiologists in San Diego.
Melanoma patients» response to a major form of immunotherapy is associated with the diversity and makeup of trillions of potential allies and enemies found in the digestive tract, researchers at The University of Texas MD Anderson
Cancer Center
report at the ASCO -
Society for Immunotherapy in
Cancer meeting in Orlando.
For women undergoing breast
cancer surgery, a technique called lipofilling — using the patient's own fat cells to optimize the results of breast reconstruction — does not increase the risk of recurrent breast
cancer,
reports a study in the February issue of Plastic and Reconstructive Surgery ®, the official medical journal of the American
Society of Plastic Surgeons (ASPS).
Now, preliminary work
reported here today at the American
Society of Human Genetics meeting suggests that men who have more CNVs than average may be more likely to sire children with the eye
cancer retinoblastoma.
In a presentation of early clinical trial data to the 20th Annual Scientific Meeting of the
Society for Neuro - Oncology, physician scientists from the University of New Mexico Comprehensive
Cancer Center
reported that a large number of study participants responded well to the drug combination.
The
report by American
Cancer Society investigators calls high rates of smoking among specific subpopulations one of the most pressing challenges facing the tobacco control community.
Dr Harbst
reported having received grants from the Swedish
Cancer Society.
A genetic test developed at UPMC proved highly sensitive at determining which pancreatic cysts are most likely to be associated with one of the most aggressive types of pancreatic
cancer, UPMC and University of Pittsburgh School of Medicine scientists
reported in Gut, the journal of the British
Society of Gastroenterology.
More than 90 percent of those young children with neuroblastoma in the lower risk or intermediate risk groups get to celebrate their 6th or 7th birthday,
reports American
Cancer Society.
At the national and international levels, she was a member of the American
Cancer Society's 2006 Committee on Nutrition and Physical Activity Guidelines for
Cancer Prevention and was also involved in the 2007 World
Cancer Research Fund International / American Institute for
Cancer Research's Second Expert
Report on Food, Nutrition, Physical Activity, and the Prevention of
Cancer.
Cancer Network presents exclusive coverage on ovarian cancer from the 2017 American Society of Clinical Oncology (ASCO) Annual Meeting, with reports on the latest clinical research changing the way ovarian cancer patients are being managed and tr
Cancer Network presents exclusive coverage on ovarian
cancer from the 2017 American Society of Clinical Oncology (ASCO) Annual Meeting, with reports on the latest clinical research changing the way ovarian cancer patients are being managed and tr
cancer from the 2017 American
Society of Clinical Oncology (ASCO) Annual Meeting, with
reports on the latest clinical research changing the way ovarian
cancer patients are being managed and tr
cancer patients are being managed and treated.
CAR T - cell therapy was also named as the American
Society of Clinical Oncology's Advance of the Year in its Clinical
Cancer Advances 2018: ASCO's Annual
Report on Progress Against
Cancer.
The
report cited a survey by the American
Society of Clinical Oncology that found 90 percent of Americans say
cancer drugs are too costly.
National
Cancer Institute; National
Cancer Institute Physician Data Query (PDQ); American
Cancer Society Facts & Figures 2016; GLOBOCAN 2012; NCI Surveillance Epidemiology and End Results (SEER); National Comprehensive
Cancer Network (NCCN) Guidelines for Patients; ClinicalTrials.gov; Melanoma Research Foundation; CRI grantee progress
reports and other CRI grantee documents
Sources: American
Cancer Society Cancer Facts & Figures 2016; GLOBOCAN 2012; SEER
Cancer Statistics Factsheets: Leukemia (National
Cancer Institute); What You Need To Know About ™ Leukemia (National
Cancer Institute); ClinicalTrials.gov; CRI grantee progress
reports and other CRI grantee documents
Sources: National
Cancer Institute; National
Cancer Institute Physician Data Query (PDQ); American
Cancer Society Facts & Figures 2016; GLOBOCAN 2012; NCI Surveillance Epidemiology and End Results (SEER); National Comprehensive
Cancer Network (NCCN) Guidelines for Patients; ClinicalTrials.gov; breastcancer.org; CRI grantee progress
reports and other CRI grantee documents
A new
report released by the American
Cancer Society has some good news for women everywhere: Between 1989 and 2015, the breast cancer death rate dropped nearly 40 percent, preventing 322,600 d
Cancer Society has some good news for women everywhere: Between 1989 and 2015, the breast
cancer death rate dropped nearly 40 percent, preventing 322,600 d
cancer death rate dropped nearly 40 percent, preventing 322,600 deaths.
And University of Arizona researchers recently
reported that postmenopausal women who most closely adhered to the American
Cancer Society's Guidelines on Nutrition and Physical Activity for Cancer Prevention, which include eating at least 2 1/2 cups of fruits and vegetables a day (no matter what kind or color), had a 22 % lower risk of breast cancer than those who complied the
Cancer Society's Guidelines on Nutrition and Physical Activity for
Cancer Prevention, which include eating at least 2 1/2 cups of fruits and vegetables a day (no matter what kind or color), had a 22 % lower risk of breast cancer than those who complied the
Cancer Prevention, which include eating at least 2 1/2 cups of fruits and vegetables a day (no matter what kind or color), had a 22 % lower risk of breast
cancer than those who complied the
cancer than those who complied the least.